{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:06:33Z","timestamp":1791893193483,"version":"4.3.4"},"reference-count":60,"publisher":"National Institute for Health and Care Research","issue":"17","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["10\/104\/30"],"award-info":[{"award-number":["10\/104\/30"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"\n Background<\/jats:title>\n Insertion of a ventriculoperitoneal shunt to treat hydrocephalus is one of the most common neurosurgical procedures worldwide. Shunt infection affects up to 15% of patients, resulting in long hospital stays, multiple surgeries and reduced cognition and quality of life.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n The aim of this trial was to determine whether or not antibiotic-impregnated ventriculoperitoneal shunts (hereafter referred to as antibiotic shunts) (e.g. impregnated with rifampicin and clindamycin) or silver-impregnated ventriculoperitoneal shunts (hereafter referred to as silver shunts) reduce infection compared with standard ventriculoperitoneal shunts (hereafter referred to as standard shunts).<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n This was a three-arm, superiority, multicentre, parallel-group randomised controlled trial. Patients and a central primary outcome review panel, but not surgeons or operating staff, were blinded to the type of ventriculoperitoneal shunt inserted.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n The trial was set in 21 neurosurgical wards across the UK and the Republic of Ireland.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n Participants were patients with hydrocephalus of any aetiology who were undergoing insertion of their first ventriculoperitoneal shunt.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Participants were allocated 1\u2009:\u20091\u2009:\u20091 by pressure-sealed envelope to receive a standard non-impregnated, silver-impregnated or antibiotic-impregnated ventriculoperitoneal shunt at the time of insertion. Ventriculoperitoneal shunts are medical devices, and were used in accordance with the manufacturer\u2019s instructions for their intended purpose.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n The primary outcome was time to ventriculoperitoneal shunt failure due to infection. Secondary outcomes were time to failure for any cause, reason for failure (infection, mechanical), types of ventriculoperitoneal shunt infection, rate of infection after first clean (non-infected) revision and health economics. Outcomes were analysed by intention to treat.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Between 26 June 2013 and 9 October 2017, 1605 patients from neonate to 91 years of age were randomised to the trial: n<\/jats:italic>\u2009=\u200936 to the standard shunt, n<\/jats:italic>\u2009=\u2009538 to the antibiotic shunt and n<\/jats:italic>\u2009=\u2009531 to the silver shunt. Patients who did not receive a ventriculoperitoneal shunt (n<\/jats:italic>\u2009=\u20094) or who had an infection at the time of insertion (n<\/jats:italic>\u2009=\u20097) were not assessed for the primary outcome. Infection occurred in 6.0% (n<\/jats:italic>\u2009=\u200932\/533) of those who received the standard shunt, in 2.2% (n<\/jats:italic>\u2009=\u200912\/535) of those who received the antibiotic shunt and in 5.9% (n<\/jats:italic>\u2009=\u200931\/526) of those who received the silver shunt. Compared with the standard shunt, antibiotic shunts were associated with a lower rate of infection (cause-specific hazard ratio 0.38, 97.5% confidence interval 0.18 to 0.80) and a decreased probability of infection (subdistribution hazard ratio 0.38, 97.5% confidence interval 0.18 to 0.80). Silver shunts were not associated with a lower rate of infection than standard shunts (cause-specific hazard ratio 0.99, 97.5% confidence interval 0.56 to 1.74). The ventriculoperitoneal shunt failure rate attributable to any cause was 25.0% overall and did not differ between arms. Antibiotic shunts save \u00a3135,753 per infection avoided. There were no serious adverse events.<\/jats:p>\n <\/jats:sec>\n \n Limitations<\/jats:title>\n It was not possible to blind treating neurosurgeons to the ventriculoperitoneal shunt type. The return rate for patient-reported outcomes was low. Limitations to the economic evaluation included failure to obtain Hospital Episode Statistics data from NHS Digital, as per protocol. Reliance on patient-level information and costing systems data mitigated these limitations.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Antibiotic shunts have a reduced infection rate compared with standard shunts, whereas silver shunts do not. Antibiotic shunts are cost-saving.<\/jats:p>\n <\/jats:sec>\n \n Future work<\/jats:title>\n A sample collection has been established that will enable the study of surrogate markers of ventriculoperitoneal shunt infection in cerebrospinal fluid or blood using molecular techniques. A post hoc analysis to study factors related to shunt failure will be performed as part of a future study. An impact analysis to assess change in practice is planned.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n Current Controlled Trials ISRCTN49474281.<\/jats:p>\n <\/jats:sec>\n \n Funding<\/jats:title>\n This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment<\/jats:italic>; Vol. 24, No. 17. See the NIHR Journals Library website for further project information.<\/jats:p>\n <\/jats:sec>","DOI":"10.3310\/hta24170","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T09:27:10Z","timestamp":1585819630000},"page":"1-114","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT"],"prefix":"10.3310","volume":"24","clinical-trial-number":[{"clinical-trial-number":"isrctn49474281","registry":"10.18810\/isrctn","type":"results"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5509-0547","authenticated-orcid":true,"given":"Conor L","family":"Mallucci","sequence":"first","affiliation":[{"name":"Department of Paediatric Neurosurgery, Alder Hey Children\u2019s NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4587-2139","authenticated-orcid":true,"given":"Michael D","family":"Jenkinson","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK"},{"name":"Institute of Translational Medicine, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4858-727X","authenticated-orcid":true,"given":"Elizabeth J","family":"Conroy","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0503-5985","authenticated-orcid":true,"given":"John C","family":"Hartley","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Great Ormond Street Hospital for Children, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7772-271X","authenticated-orcid":true,"given":"Michaela","family":"Brown","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5579-996X","authenticated-orcid":true,"given":"Tracy","family":"Moitt","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1199-3047","authenticated-orcid":true,"given":"Joanne","family":"Dalton","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5416-8376","authenticated-orcid":true,"given":"Tom","family":"Kearns","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1851-6155","authenticated-orcid":true,"given":"Michael J","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Institute of Infection and Global Health, University of Liverpool, Liverpool, UK"},{"name":"Department of Paediatric Neurology, Alder Hey Children\u2019s NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5032-4255","authenticated-orcid":true,"given":"Giovanna","family":"Culeddu","sequence":"additional","affiliation":[{"name":"Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7266-6547","authenticated-orcid":true,"given":"Tom","family":"Solomon","sequence":"additional","affiliation":[{"name":"Institute of Infection and Global Health, University of Liverpool, Liverpool, UK"},{"name":"Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8247-7459","authenticated-orcid":true,"given":"Dyfrig","family":"Hughes","sequence":"additional","affiliation":[{"name":"Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3021-1955","authenticated-orcid":true,"given":"Carrol","family":"Gamble","sequence":"additional","affiliation":[{"name":"Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the BASICS study collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2020,3]]},"reference":[{"key":"key20200401162753762_ref1-bib1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1745-6215-15-4","article-title":"The British antibiotic and silver-impregnated catheters for ventriculoperitoneal shunts multi-centre randomised controlled trial (the BASICS trial): study protocol","volume":"15","author":"Jenkinson","year":"2014","journal-title":"Trials"},{"key":"key20200401162753762_ref1-bib2","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/S0140-6736(19)31603-4","article-title":"Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation","volume":"394","author":"Mallucci","year":"2019","journal-title":"Lancet"},{"key":"key20200401162753762_ref1-bib3","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3171\/2017.10.JNS17439","article-title":"Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis","volume":"130","author":"Dewan","year":"2018","journal-title":"J Neurosurg"},{"key":"key20200401162753762_ref1-bib4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3171\/2009.4.PEDS09210","article-title":"Efficacy of antibiotic-impregnated shunt catheters in reducing shunt infection: data from the United Kingdom Shunt Registry","volume":"4","author":"Richards","year":"2009","journal-title":"J Neurosurg Pediatr"},{"key":"key20200401162753762_ref1-bib5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00381-005-0037-8","article-title":"Cerebrospinal fluid shunt infection: risk factors and long-term follow-up","volume":"22","author":"Vinchon","year":"2006","journal-title":"Childs Nerv Syst"},{"key":"key20200401162753762_ref1-bib6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/bf01411427","article-title":"Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts","volume":"136","author":"Borgbjerg","year":"1995","journal-title":"Acta Neurochir"},{"key":"key20200401162753762_ref1-bib7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3171\/jns.1992.77.6.0875","article-title":"Shunt implantation: reducing the incidence of shunt infection","volume":"77","author":"Choux","year":"1992","journal-title":"J Neurosurg"},{"key":"key20200401162753762_ref1-bib8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00701-002-1068-5","article-title":"CSF shunt infections in children: experiences from a population-based study","volume":"145","author":"Enger","year":"2003","journal-title":"Acta Neurochir"},{"key":"key20200401162753762_ref1-bib9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3171\/jns.1992.77.1.0029","article-title":"Infection of cerebrospinal fluid shunts in infants: a study of etiological factors","volume":"77","author":"Pople","year":"1992","journal-title":"J Neurosurg"},{"key":"key20200401162753762_ref1-bib10","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1097\/00006454-199509000-00010","article-title":"Cerebrospinal fluid shunt infections in children","volume":"14","author":"Ronan","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"key20200401162753762_ref1-bib11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/00006454-200207000-00006","article-title":"Treatment of cerebrospinal fluid shunt infections: a decision analysis","volume":"21","author":"Schreffler","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"key20200401162753762_ref1-bib12","doi-asserted-by":"publisher","first-page":"A78","DOI":"10.1136\/jnnp-2017-ABN.271","article-title":"PO250 study of the feasibility and accuracy of next generation sequencing, proteomics, transcriptomics and cytokine measurement for improving the diagnosis of neurosurgical cerebrospinal fluid infection","volume":"88","author":"van Tonder","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20200401162753762_ref1-bib13","first-page":"494","volume-title":"Cerebrospinal Fluid Disorders","author":"Richards","year":"2010"},{"key":"key20200401162753762_ref1-bib14","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/00006123-199808000-00068","article-title":"Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus","volume":"43","author":"Drake","year":"1998","journal-title":"Neurosurgery"},{"key":"key20200401162753762_ref1-bib15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3171\/jns.2003.99.5.0831","article-title":"Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus","volume":"99","author":"Govender","year":"2003","journal-title":"J Neurosurg"},{"key":"key20200401162753762_ref1-bib16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00381-007-0521-4","article-title":"The impact of antibiotic-impregnated catheters on shunt infection in children and neonates","volume":"24","author":"Hayhurst","year":"2008","journal-title":"Childs Nerv Syst"},{"key":"key20200401162753762_ref1-bib17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00381-010-1290-z","article-title":"Antibiotic-impregnated ventriculoperitoneal shunts \u2013 a multi-centre British paediatric neurosurgery group (BPNG) study using historical controls","volume":"27","author":"Kandasamy","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"key20200401162753762_ref1-bib18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/jac\/dkp420","article-title":"In vitro antimicrobial activity of silver-processed catheters for neurosurgery","volume":"65","author":"Bayston","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key20200401162753762_ref1-bib19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1159\/000172966","article-title":"Comparison of the efficacies of antibiotic-impregnated and silver-impregnated ventricular catheters on the prevention of infections. An in vitro laboratory study","volume":"44","author":"Secer","year":"2008","journal-title":"Pediatr Neurosurg"},{"key":"key20200401162753762_ref1-bib20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1179\/174313209X380973","article-title":"Initial experience with silver-impregnated polyurethane ventricular catheter for shunting of cerebrospinal fluid in patients with infected hydrocephalus","volume":"31","author":"Izci","year":"2009","journal-title":"Neurol Res"},{"key":"key20200401162753762_ref1-bib21","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3171\/2009.8.JNS091297","article-title":"Efficacy of silver-bearing external ventricular drainage catheters: a retrospective analysis","volume":"112","author":"Fichtner","year":"2010","journal-title":"J Neurosurg"},{"key":"key20200401162753762_ref1-bib22","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1227\/NEU.0b013e318257bebb","article-title":"The SILVER (Silver Impregnated Line Versus EVD Randomized trial): a double-blind, prospective, randomized, controlled trial of an intervention to reduce the rate of external ventricular drain infection","volume":"71","author":"Keong","year":"2012","journal-title":"Neurosurgery"},{"key":"key20200401162753762_ref1-bib23","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/02688697.2011.603856","article-title":"Antibiotic-impregnated catheters for the prevention of CSF shunt infections: a systematic review and meta-analysis","volume":"26","author":"Thomas","year":"2012","journal-title":"Br J Neurosurg"},{"key":"key20200401162753762_ref1-bib24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s12028-008-9071-1","article-title":"Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus","volume":"8","author":"Lackner","year":"2008","journal-title":"Neurocrit Care"},{"key":"key20200401162753762_ref1-bib25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3171\/ped.2004.101.2.0134","article-title":"An instrument to measure the health status in children with hydrocephalus: the Hydrocephalus Outcome Questionnaire","volume":"101","author":"Kulkarni","year":"2004","journal-title":"J Neurosurg"},{"key":"key20200401162753762_ref1-bib26","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1002\/sim.1271","article-title":"Dealing with competing risks: testing covariates and calculating sample size","volume":"21","author":"Pintilie","year":"2002","journal-title":"Stat Med"},{"key":"key20200401162753762_ref1-bib27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1259\/0007-1285-44-526-793","article-title":"Repeated assessment of results in clinical trials of cancer treatment","volume":"44","author":"Haybittle","year":"1971","journal-title":"Br J Radiol"},{"key":"key20200401162753762_ref1-bib28","volume-title":"Simultaneous Statistical Inference","author":"Miller","year":"1966"},{"key":"key20200401162753762_ref1-bib29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"key20200401162753762_ref1-bib30","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jclinepi.2012.09.017","article-title":"A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions","volume":"66","author":"Latouche","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"key20200401162753762_ref1-bib31","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine\u2013Gray model analyses for competing risk data","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"key":"key20200401162753762_ref1-bib32","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3171\/PED\/2008\/1\/6\/444","article-title":"Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters","volume":"1","author":"Eymann","year":"2008","journal-title":"J Neurosurg Pediatr"},{"key":"key20200401162753762_ref1-bib33","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.wneu.2010.07.014","article-title":"Cost analysis of antibiotic-impregnated catheters in the treatment of hydrocephalus in adult patients","volume":"74","author":"Farber","year":"2010","journal-title":"World Neurosurg"},{"key":"key20200401162753762_ref1-bib34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1227\/01.NEU.0000363405.12584.4D","article-title":"Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters","volume":"66","author":"Attenello","year":"2010","journal-title":"Neurosurgery"},{"key":"key20200401162753762_ref1-bib35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1227\/neu.0b013e318226ffe5","article-title":"Comparison of hospital cost and resource use associated with antibiotic-impregnated versus standard shunt catheters","volume":"58","author":"Parker","year":"2011","journal-title":"Clin Neurosurg"},{"key":"key20200401162753762_ref1-bib36","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.wneu.2014.06.010","article-title":"Cost savings associated with antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus","volume":"83","author":"Parker","year":"2015","journal-title":"World Neurosurg"},{"key":"key20200401162753762_ref1-bib37","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.wneu.2015.09.032","article-title":"Antibiotic impregnated external ventricular drains: meta and cost analysis","volume":"86","author":"Root","year":"2016","journal-title":"World Neurosurg"},{"key":"key20200401162753762_ref1-bib38","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3171\/2011.8.PEDS11346","article-title":"Antibiotic-impregnated shunt systems versus standard shunt systems: a meta- and cost-savings analysis","volume":"8","author":"Klimo","year":"2011","journal-title":"J Neurosurg Pediatr"},{"key":"key20200401162753762_ref1-bib39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3171\/2014.9.JNS131277","article-title":"Cost\u2013consequence analysis of antibiotic-impregnated shunts and external ventricular drains in hydrocephalus","volume":"122","author":"Edwards","year":"2015","journal-title":"J Neurosurg"},{"key":"key20200401162753762_ref1-bib40","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1524-4733.2010.00788.x","article-title":"Methods for the collection of resource use data within clinical trials: a systematic review of studies funded by the UK Health Technology Assessment program","volume":"13","author":"Ridyard","year":"2010","journal-title":"Value Health"},{"key":"key20200401162753762_ref1-bib41","volume-title":"BASICS Health Service Diary","author":"Database of Instruments for Resource Use Measurement"},{"key":"key20200401162753762_ref1-bib42","volume-title":"Unit Costs of Health and Social Care 2017","author":"Curtis","year":"2017"},{"key":"key20200401162753762_ref1-bib43","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/hec.1785","article-title":"Spoilt for choice: implications of using alternative methods of costing hospital episode statistics","volume":"21","author":"Geue","year":"2012","journal-title":"Health Econ"},{"key":"key20200401162753762_ref1-bib44","volume-title":"NHS Reference Costs 2015 to 2016","author":"Department of Health and Social Care"},{"key":"key20200401162753762_ref1-bib45","volume-title":"NHS National Tariff Payment System 2016\/17","author":"NHS England"},{"key":"key20200401162753762_ref1-bib46","unstructured":"Joint Formulary Committee. British National Formulary. 74th ed. London: BMJ Group and Pharmaceutical Press; 2017."},{"key":"key20200401162753762_ref1-bib47","volume-title":"Prescription Cost Analysis Data","author":"NHS Business Services Authority"},{"key":"key20200401162753762_ref1-bib48","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"key20200401162753762_ref1-bib49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3171\/ped.2004.101.2.0141","article-title":"Measuring the health status of children with hydrocephalus by using a new outcome measure","volume":"101","author":"Kulkarni","year":"2004","journal-title":"J Neurosurg"},{"key":"key20200401162753762_ref1-bib50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s41669-017-0015-6","article-title":"Handling missing data in within-trial cost-effectiveness analysis: a review with future recommendations","volume":"1","author":"Gabrio","year":"2017","journal-title":"Pharmacoecon Open"},{"key":"key20200401162753762_ref1-bib51","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s40273-019-00771-y","article-title":"An educational review about using cost data for the purpose of cost-effectiveness analysis","volume":"37","author":"Franklin","year":"2019","journal-title":"PharmacoEconomics"},{"key":"key20200401162753762_ref1-bib52","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"key20200401162753762_ref1-bib53","volume-title":"Guide to the Methods of Technology Appraisal 2013","author":"National Institute for Health and Care Excellence"},{"key":"key20200401162753762_ref1-bib54","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/hec.1653","article-title":"Review of statistical methods for analysing healthcare resources and costs","volume":"20","author":"Mihaylova","year":"2011","journal-title":"Health Econ"},{"key":"key20200401162753762_ref1-bib55","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2165\/00019053-200927030-00001","article-title":"Costing and cost analysis in randomized controlled trials: caveat emptor","volume":"27","author":"Polsky","year":"2009","journal-title":"PharmacoEconomics"},{"key":"key20200401162753762_ref1-bib56","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/hec.635","article-title":"Representing uncertainty: the role of cost-effectiveness acceptability curves","volume":"10","author":"Fenwick","year":"2001","journal-title":"Health Econ"},{"key":"key20200401162753762_ref1-bib57","doi-asserted-by":"publisher","first-page":"f1049","DOI":"10.1136\/bmj.f1049","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"346","author":"Husereau","year":"2013","journal-title":"BMJ"},{"key":"key20200401162753762_ref1-bib58","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11121-007-0070-9","article-title":"How many imputations are really needed? Some practical clarifications of multiple imputation theory","volume":"8","author":"Graham","year":"2007","journal-title":"Prev Sci"},{"key":"key20200401162753762_ref1-bib59","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/jnnp-2017-316415","article-title":"Prospective, multicentre study of external ventricular drainage-related infections in the UK and Ireland","volume":"89","author":"Jamjoom","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20200401162753762_ref1-bib60","volume-title":"Regulation (EU) 2016\/679 of the European Parliament and of the Council of 27 April 2016 on the Protection of Natural Persons With Regard to the Processing of Personal Data and on the Free Movement of Such Data, and Repealing Directive 95\/46\/EC (General Data Protection Regulation)","author":"European Parliament"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta24170\/hta24170.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2010977","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta24170\/hta24170.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2032250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:57:05Z","timestamp":1692115025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta24170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":60,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["10.3310\/hta24170"],"URL":"https:\/\/doi.org\/10.3310\/hta24170","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}